MAUREEN GEARY: Open Payments
NPI 1609936046 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,032 in 25 payments from 8 companies in 2025. Trend: 2023 $1,636 · 2024 $3,083 · 2025 $4,032
Speaker / faculty: $2,520Food & beverage: $793Travel & lodging: $719
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 10 | $3,586 |
| Abbott Laboratories | 4 | $156 |
| Alnylam Pharmaceuticals Inc. | 2 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 2 | $55 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| PFIZER INC. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Attruby, CARDIOMEMS, AMVUTTRA, LEQVIO, WAINUA, VERQUVO, VYNDAQEL, CAMZYOS.
Industry payments across NY — which companies pay providers there.
